Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) after a mass vaccination campaign with meningococcal C conjugated vaccine

By Salleras L.   Domnguez A.   Cardenosa N.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 729-733

Elsevier

Access to resources Recommend Favorite

Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-nave controls

By Borrow R.   Southern J.   Andrews N.   Peake N.   Rahim R.   Acuna M.   Martin S.   Miller E.   Kaczmarski E.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3043-3050

Elsevier

Access to resources Recommend Favorite

Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec

By De Wals P.   Erickson L.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2840-2844

Elsevier

Access to resources Recommend Favorite

Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate

By Fukasawa L.O.   Gorla M.C.O.   Schenkman R.P.F.   Garcia L.R.   Carneiro S.M.   Raw I.   Tanizaki M.M.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 2951-2958

Elsevier

Access to resources Recommend Favorite

Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial

By Choo S.   Zuckerman J.   Goilav C.   Hatzmann E.   Everard J.   Finn A.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2686-2692

Elsevier

Access to resources Recommend Favorite